The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Abstract
Great emphasis is being placed on identification of neurotransmitter systems involved in the symptomatic manifestations of neurological and psychiatric disorders. In the case of Alzheimer's disease, which now seems to be one of the most common causes of mental deterioration in the elderly, compelling evidence has been developed that acetylcholine-releasing neurons, whose cell bodies lie in the basal forebrain, selectively degenerate. These cholinergic neurons provide widespread innervation of the cerebral cortex and related structures and appear to play an important role in cognitive functions, especially memory. These advances reflect a close interaction between experimental and clinical neuroscientists in which information derived from basic neurobiology is rapidly utilized to analyze disorders of the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Self-citationHökfelt, T., Johansson, O., Ljungdahl, Å., Lundberg, J. M., & Schultzberg, M. (1980) · Nature · doi:10.1038/284515a0 · Cited by 1,547
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Krettek, J. E., & Price, J. L. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780204 · Cited by 1,293
Cited by
Items 101–200 of 214
Coyle, J., & Kershaw, P. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01101-x · Cited by 335
Self-citationGlutamate dysfunction in Alzheimer's disease: an hypothesis
Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 334
Alterations in L-Glutamate Binding in Alzheimer's and Huntington's Diseases
Greenamyre, J. T., Penney, J. B., Young, A. B., D'Amato, C. J., Hicks, S. P., & Shoulson, I. (1985) · Science · doi:10.1126/science.2858129 · Cited by 333
Baxter, M. G., Bucci, D. J., Gorman, L. K., Wiley, R. G., & Gallagher, M. (2013) · Behavioral Neuroscience · doi:10.1037/a0033939 · Cited by 331
Nurturing brain plasticity: Impact of environmental enrichment
Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Sale, A., & Maffei, L. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.193 · Cited by 330
Torres, E. M., Perry, T. A., Blokland, A., Wilkinson, L. S., Wiley, R. G., Lappi, D. A., & Dunnett, S. B. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90010-8 · Cited by 329
Holsinger, R. M. D., Schnarr, J., Henry, P., Castelo, V. T., & Fahnestock, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00023-1 · Cited by 328
The nerve growth factor family
Barde, Y.-A. (1990) · Progress in Growth Factor Research · doi:10.1016/0955-2235(90)90021-b · Cited by 328
Transmitter deficits in Alzheimer's disease
Hardy, J., Adolfsson, R., Alafuzoff, I., Bucht, G., Marcusson, J., Nyberg, P., Perdahl, E., Wester, P., & Winblad, B. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90050-6 · Cited by 328
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Sultana, R., & Butterfield, D. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1222 · Cited by 327
Berger-Sweeney, J., Heckers, S., Mesulam, M., Wiley, R., Lappi, D., & Sharma, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04507.1994 · Cited by 327
The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system
Decker, M. W. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90007-5 · Cited by 323
Excitatory amino acids and neuropsychiatrie disorders
Olney, J. W. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90072-3 · Cited by 322
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease
Nordberg, A., Ballard, C., Bullock, R., Darreh-Shori, T., & Somogyi, M. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01412 · Cited by 323
Melander, T., Staines, W. A., Hökfelt, T., Rökaeus, Å., Eckenstein, F., Salvaterra, P. M., & Wainer, B. H. (1985) · Brain Research · doi:10.1016/0006-8993(85)91228-4 · Cited by 318
Down's Syndrome and Alzheimer's disease: a review
Oliver, C., & Holland, A. J. (1986) · Psychological Medicine · doi:10.1017/s0033291700009120 · Cited by 316
Zhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., & Wess, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01709.2002 · Cited by 315
Kang, T.-H., Matsumoto, K., Tohda, M., Murakami, Y., Takayama, H., Kitajima, M., Aimi, N., & Watanabe, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01608-4 · Cited by 315
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Intravenous nicotine in Alzheimer's disease: a pilot study
Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Cirulli, F., Berry, A., & Alleva, E. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00010-1 · Cited by 303
“In mammals, these neurons play a functional role in learning and memory [92,93].”
BackgroundGupta, A., Bisht, B., & Dey, C. S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.033 · Cited by 302
Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301
Two types of muscarinic response to acetylcholine in mammalian cortical neurons.
McCormick, D. A., & Prince, D. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6344 · Cited by 299
Murray, C. L., & Fibiger, H. C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90273-8 · Cited by 299
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Lombardo, S., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 299
Mufson, E. J., Kroin, J. S., Sendera, T. J., & Sobreviela, T. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00059-8 · Cited by 298
Luiten, P. G. M., Gaykema, R. P. A., Traber, J., & Spencer, D. G. (1987) · Brain Research · doi:10.1016/0006-8993(87)91014-6 · Cited by 295
Vallée, M., Mayo, W., Darnaudéry, M., Corpéchot, C., Young, J., Koehl, M., Le Moal, M., Baulieu, E.-E., Robel, P., & Simon, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14865 · Cited by 293
Chonpathompikunlert, P., Wattanathorn, J., & Muchimapura, S. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.009 · Cited by 291
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain
Hefti, F., Hartikka, J., Salvatierra, A., Weiner, W. J., & Mash, D. C. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90410-6 · Cited by 290
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
Goldberg, T. E., Greenberg, R. D., Griffin, S. J., Gold, J. M., Kleinman, J. E., Pickar, D., Schulz, S. C., & Weinberger, D. R. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.43 · Cited by 289
Di Lazzaro, V., Oliviero, A., Tonali, P. A., Marra, C., Daniele, A., Profice, P., Saturno, E., Pilato, F., Masullo, C., & Rothwell, J. C. (2002) · Neurology · doi:10.1212/wnl.59.3.392 · Cited by 288
Cholinergic systems in mammalian brain identified with antibodies against choline acetyltransferase
Wainer, B. H., Levey, A. I., Mufson, E. J., & Mesulam, M.-M. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90089-5 · Cited by 287
Corte´s, R., Probst, A., Tobler, H.-J., & Palacios, J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90449-x · Cited by 286
The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress
Wenk, G. L. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.3757 · Cited by 286
Tuszynski, M., U, H., Amaral, D., & Gage, F. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-11-03604.1990 · Cited by 282
Muir, J. L., Dunnett, S. B., Robbins, T. W., & Everitt, B. J. (1992) · Experimental Brain Research · doi:10.1007/bf00229886 · Cited by 280
Mufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Antioxidants, Aging, and Longevity
Cutler, R. G. (1984) · Free Radicals in Biology · doi:10.1016/b978-0-12-566506-3.50019-4 · Cited by 279
Levey, A. I., Wainer, B. H., Rye, D. B., Mufson, E. J., & Mesulam, M.-M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90234-3 · Cited by 276
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
Cummings, J. L., & Back, C. (1998) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00009 · Cited by 274
Fractional Gaussian noise, functional MRI and Alzheimer's disease
Maxim, V., Şendur, L., Fadili, J., Suckling, J., Gould, R., Howard, R., & Bullmore, E. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.044 · Cited by 272
Cholinesterase Inhibitors for Alzheimer??s Disease
Grutzendler, J., & Morris, J. C. (2001) · Drugs · doi:10.2165/00003495-200161010-00005 · Cited by 270
Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients
Morrison, J. H., Rogers, J., Scherr, S., Benoit, R., & Bloom, F. E. (1985) · Nature · doi:10.1038/314090a0 · Cited by 264
Zheng, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.001 · Cited by 264
Muscarinic cholinergic influences in memory consolidation
Power, A. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00086-8 · Cited by 261
Decker, M. W., Brioni, J. D., Bannon, A. W., & Arneric, S. P. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00488-e · Cited by 260
Maurer, S. V., & Williams, C. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01489 · Cited by 260
Sleep-related neuronal discharge in the basal forebrain of cats
Szymusiak, R., & McGinty, D. (1986) · Brain Research · doi:10.1016/0006-8993(86)91107-8 · Cited by 259
Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: A Review
Lye, T. C., & Shores, E. A. (2000) · Neuropsychology Review · doi:10.1023/a:1009068804787 · Cited by 258
Chan‐Palay, V. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902600205 · Cited by 254
Autoradiographic distribution of nicotine receptors in rat brain
Clarke, P. B. S., Pert, C. B., & Pert, A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90320-2 · Cited by 253
Fisahn, A., Yamada, M., Duttaroy, A., Gan, J.-W., Deng, C.-X., McBain, C. J., & Wess, J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00587-1 · Cited by 252
The neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248
Self-citationNeuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
Lysakowski, A., Wainer, B. H., Bruce, G., & Hersh, L. B. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90180-2 · Cited by 239
Cognitive Test Performance in Detecting, Staging, and Tracking Alzheimer's Disease
Locascio, J. J., Growdon, J. H., & Corkin, S. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540350081020 · Cited by 228
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease
Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223
Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215
SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
Lee, J., Kim, Y., Liu, T., Hwang, Y. J., Hyeon, S. J., Im, H., Lee, K., Alvarez, V. E., McKee, A. C., Um, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12679 · Cited by 213
“…of subcortical cholinergic basal forebrain neurons may lead to the dysfunction of gamma-amino butyric acid (GABA)ergic and glutamatergic neuronal systems, and degeneration of subcortical serotonergic and aminergic nuclei may also contribute to AD symptoms (Coyle et al., 1983; Canter et al., 2016).”
BackgroundSome Speculations about Prions, Amyloid, and Alzheimer's Disease
Prusiner, S. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403083101021 · Cited by 213
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Arneric, S. P., Holladay, M., & Williams, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.033 · Cited by 208
“[5] Coyle JT, Price DL, DeLong MR.”
BackgroundSex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
Muir, J. L., Page, K. J., Sirinathsinghji, D. J. S., Robbins, T. W., & Everitt, B. J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90128-d · Cited by 199
Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196
Dalley, J. W. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh052 · Cited by 191
Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
Molchan, S. E., Martinez, R. A., Hill, J. L., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 187
Knowles, J. K., Rajadas, J., Nguyen, T.-V. V., Yang, T., LeMieux, M. C., Vander Griend, L., Ishikawa, C., Massa, S. M., Wyss-Coray, T., & Longo, F. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0620-09.2009 · Cited by 184
Reimagining cholinergic therapy for Alzheimer’s disease
Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187
Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142356 · Cited by 176
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice
Gordon, I., Grauer, E., Genis, I., Sehayek, E., & Michaelson, D. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12006-p · Cited by 172
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160
“Besides the extracellular deposition of A, the AD brain is characterized by intracellular neurofibrillary tangles and profound changes in the cholinergic system (Bartus et al., 1982; Coyle et al., 1983; Goedert, 1993).”
BackgroundInfluentialCholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus
Vogt, K. E., & Regehr, W. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00075.2001 · Cited by 149
Md, S., Ali, M., Baboota, S., Sahni, J. K., Bhatnagar, A., & Ali, J. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.758130 · Cited by 138
Turrini, P., Casu, M. A., Wong, T. P., De Koninck, Y., Ribeiro-da-Silva, A., & Cuello, A. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00172-5 · Cited by 135
Cortical Cholinergic Dysfunction After Human Head Injury
MURDOCH, I., PERRY, E. K., COURT, J. A., GRAHAM, D. I., & DEWAR, D. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.295 · Cited by 121
Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116
Farías, G. G., Vallés, A. S., Colombres, M., Godoy, J. A., Toledo, E. M., Lukas, R. J., Barrantes, F. J., & Inestrosa, N. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3934-06.2007 · Cited by 108
Cea-del Rio, C. A., Lawrence, J. J., Tricoire, L., Erdelyi, F., Szabo, G., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5040-09.2010 · Cited by 99
Bayraktar, T., Staiger, J. F., Acsady, L., Cozzari, C., Freund, T. F., & Zilles, K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00218-7 · Cited by 99
Bitner, R. S., Bunnelle, W. H., Decker, M. W., Drescher, K. U., Kohlhaas, K. L., Markosyan, S., Marsh, K. C., Nikkel, A. L., Browman, K., Radek, R., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167213 · Cited by 97
“ACh plays a critical role in cognition, as degeneration/dysfunction of cholinergic neurons is closely associated with cognitive deficits of AD (Coyle et al., 1983); it may be expected that 7 agonists like ABT-107 would be expected to release ACh, in addition to other neurotransmitters.”
BackgroundCentral blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
Chen, K. C., Baxter, M. G., & Rodefer, J. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03548.x · Cited by 97
“Indeed, it has been proposed that disruption of this input to frontal cortex is responsible for some of the cognitive deficits in Alzheimer’s disease (Coyle et al., 1983; Sahakian et al., 1993).”
BackgroundBacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Blurton-Jones, M. M., Roberts, J. A., & Tuszynski, M. H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990322)405:4<529::aid-cne6>3.0.co;2-y · Cited by 95
The Thyroid in Mind: Cognitive Function and Low Thyrotropin in Older People
Gan, E. H., & Pearce, S. H. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2284 · Cited by 93
Behavior and Treatment in Frontotemporal Dementia
Perry, R. J., & Miller, B. L. (2001) · Neurology · doi:10.1212/wnl.56.suppl_4.s46 · Cited by 90
Glucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
Wang, Q., Li, W.-X., Dai, S.-X., Guo, Y.-C., Han, F.-F., Zheng, J.-J., Li, G.-H., & Huang, J.-F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161032 · Cited by 88
“1B; TNF signaling pathway [38], cholinergic synapse [39], and glutamatergic synapse [36], were the significant pathways that enriched by up and downregulated DEGs of PC, which were shown in Supplementary Table 4.”
BackgroundDecker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37015-6 · Cited by 88
Aubert, C. E., Bauer, D. C., da Costa, B. R., Feller, M., Rieben, C., Simonsick, E. M., Yaffe, K., Rodondi, N., & Study, T. H. A. (2017) · Clinical Endocrinology · doi:10.1111/cen.13458 · Cited by 87
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80
Allen, T. G. J., Abogadie, F. C., & Brown, D. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3979-05.2006 · Cited by 79
Christensen, D. Z., Bayer, T. A., & Wirths, O. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.022 · Cited by 77
Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73
Zhong, P., Gu, Z., Wang, X., Jiang, H., Feng, J., & Yan, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302789200 · Cited by 71
Pentz, R., Iulita, M. F., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0797-2 · Cited by 68
Farías, G. G., Godoy, J. A., Hernández, F., Avila, J., Fisher, A., & Inestrosa, N. C. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.016 · Cited by 59
Metadata
- Authors
- Coyle, J. T., Price, D. L., & DeLong, M. R.
- Venue
- Science
- Published
- 1983-03-11
- Volume
- 219
- Issue
- 4589
- Pages
- 1184-1190
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2021280501
- Cited by
- 3,052
- References
- 92
- FWCI
- 124.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.